PHVS today
$33.83-$0.35 (-1.02%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourExpanding
1 hourLeaning Bearish
15 minSymmetric Triangle
5 minLeaning Bearish
Daily trend turns up above $43.25
Key levels
Resistance$38.13
Resistance$35.41
Support$33.80
Support$31.60
Latest news & SEC filings
SEC FilingPharvaris N.V. filed an insider trading report (Form 4)
EarningsPharvaris Posts Q3 2026 Results
EarningsPharvaris reports Q3 loss of $0.77 per share, beating $0.82 estimate
EarningsPharvaris posts quarterly loss of €0.67 per share
All PHVS news →About Pharvaris
Pharvaris is a clinical-stage biopharmaceutical company developing oral therapies for hereditary angioedema (HAE). Its product candidates include IR and XR formulations. The company operates in the United States and Europe, targeting patients with HAE and healthcare providers.
Based on the company's 20-F filed Apr 2, 2026.
Nasdaq · Healthcare
Pharvaris N.V. (PHVS)
What Is the Price Target for PHVS?
SEPT Low Target
$42.00
SEPT Mid Target
$56.00
SEPT High Target
$79.00
Analyst Consensus
$56.00
Is PHVS a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PHVS.
Start Free Trial →Is PHVS Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$56.00
12
Moat Score
NONE
1/9
Piotroski Score
29.7
Altman Z-Score
What Is Smart Money Doing with PHVS?
Insider Signal
SELLING
0 buys / 10 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Monges Viviane | director | Buy | 11,969 | $96K | Sep 23, 2026 |
| Monges Viviane | director | Sale | 11,969 | $396K | Sep 23, 2026 |
| Lu Peng | officer | Buy | 45,308 | $117K | Sep 22, 2026 |
| Schikan Johannes Gerardus Christiaan Petrus | director | Buy | 800 | $16K | Sep 22, 2026 |
| Schikan Johannes Gerardus Christiaan Petrus | director | Sale | 800 | $29K | Sep 22, 2026 |
| Nassif David W. | officer | Sale | 6,000 | $219K | Sep 21, 2026 |
| Nassif David W. | officer | Sale | 500 | - | Sep 21, 2026 |
| Bjork Elisabeth | director | Buy | 35,000 | $504K | Sep 17, 2026 |
| Bjork Elisabeth | director | Buy | 17,500 | $317K | Sep 17, 2026 |
| Bjork Elisabeth | director | Sale | 52,500 | $2.0M | Sep 17, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PHVS Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-24.93%
FCF Growth YoY
-18.6%
Revenue Trend
UNKNOWN
Dark Pool Trades for PHVS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PHVS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:06 | $33.83 | 1,100 | $$37K | SELL |
| 21:00:06 | $33.83 | 2,800 | $$95K | SELL |
| 20:58:03 | $33.81 | 1,090 | $$37K | BUY |
| 20:33:26 | $34.01 | 1,000 | $$34K | SELL |
| 20:18:21 | $34.06 | 1,000 | $$34K | SELL |
5 dark pool trades shown · $$237K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PHVS
PREVIEWSEPT Investing provides real-time options flow tracking for PHVS, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $55 | Dec 18 | 36 | $$45 | 3 | SWEEP |
| PUT | $32.5 | Nov 20 | 8 | $$80 | 1 | SWEEP |
| PUT | $32.5 | Nov 20 | 8 | $$80 | 1 | SWEEP |
| PUT | $32.5 | Nov 20 | 8 | $$80 | 1 | SWEEP |
| PUT | $32.5 | Nov 20 | 8 | $$80 | 1 | SWEEP |
5 options trades shown · 20% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About PHVS
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for PHVS. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
PHVS filed an insider trading report (Form 4).
Join 3,500+ traders discussing PHVS in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Pharvaris N.V. (PHVS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PHVS — frequently asked questions
What is PHVS stock price today?
Pharvaris N.V. (PHVS) is at $33.83, down 1.02% (-$0.35) at the Nov 12, 2026 close.
Why is PHVS stock down today?
Nov 12, 2026: Pharvaris N.V. (PHVS) closed at $33.83, up 0.71% on the day, trading between a low of $33.00 and a high of $34.55 on volume of 367,858 shares.
What is the PHVS price target?
The average analyst price target for PHVS is $56.00, ranging from $42 to $79, based on 10 analysts. Latest: B of A Securities upgrade on Oct 23, 2026.
What do analysts rate PHVS?
Analyst ratings for PHVS: 4 Buy, 16 Hold, 0 Sell — consensus Hold.
Did PHVS beat earnings?
PHVS last reported on Nov 11, 2026: EPS -$0.77 vs -$0.82 expected — a beat of 6.1%.
Does PHVS pay a dividend?
PHVS does not currently pay a dividend.
What are PHVS support and resistance levels?
Support: $33.80, $31.60, $29.83. Resistance: $35.41, $38.13, $43.25.
What are insiders doing with PHVS?
Insider activity: SELLING, 0 buys and 10 sells in the last 90 days.
What is the latest news on PHVS?
Nov 12, 2026: Pharvaris N.V. filed an insider trading report (Form 4) · Nov 12, 2026: Pharvaris Posts Q3 2026 Results · Nov 12, 2026: Pharvaris reports Q3 loss of $0.77 per share, beating $0.82 estimate